Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

1,274 total articles

Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets

Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets

Nano-X Imaging Ltd. (NASDAQ: NNOX) announced a distribution agreement with Elite Surgical Technologies to deploy the Nanox.ARC digital tomosynthesis imaging system across five U.S. states, targeting orthopedic practices and post-surgical care settings. The partnership aims to enhance adoption of cost-effective, low-radiation 3D imaging to monitor b…

WTW completes acquisition of FlowStone Partners

WTW completes acquisition of FlowStone Partners

Willis Towers Watson (WTW) has completed the acquisition of FlowStone Partners, an alternative investment firm specializing in private equity secondaries. This move enhances WTW's Investments business by expanding access to private equity solutions for individual wealth investors and bringing advanced investment capabilities to institutional client…

Greenlane Holdings, Inc. Announces 1-for-8 Reverse Stock Split

Greenlane Holdings, Inc. Announces 1-for-8 Reverse Stock Split

Greenlane Holdings, Inc., a Nasdaq-listed digital asset treasury company focused on Berachain blockchain assets, announced a 1-for-8 reverse stock split effective April 6, 2026. The split aims to improve the perception of its stock, broaden investor appeal, and maintain compliance with Nasdaq listing rules. The total shares outstanding will reduce …

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

Cogent Biosciences has completed the submission of a New Drug Application (NDA) to the FDA for bezuclastinib in treatment-resistant Gastrointestinal Stromal Tumors (GIST) patients, based on strong Phase 3 PEAK trial results. The application was submitted under the FDA's expedited Real-Time Oncology Review program. The PEAK trial demonstrated signif…

electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD

electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD

electroCore, Inc. announced the publication of clinical findings demonstrating that adjunctive non-invasive vagus nerve stimulation (nVNS) significantly reduces symptoms in patients with chronic mild traumatic brain injury (mTBI) and comorbid post-traumatic stress disorder (PTSD). The study showed improvements across cognitive, affective, and somat…

Live Ventures Company Central Steel Fabricators Contributes to Hyperscale AI Data Center Infrastructure Expansion

Live Ventures Company Central Steel Fabricators Contributes to Hyperscale AI Data Center Infrastructure Expansion

Live Ventures Incorporated's subsidiary, Central Steel Fabricators, announced its role in supplying structural support products for a major hyperscale data center project driven by AI adoption. The company emphasizes its capability to deliver high-quality steel systems essential for data center connectivity and infrastructure, highlighting ongoing …

Willis Lease Finance Corporation Closes Two Additional JOLCO Deals, Bringing Total JOLCO Financing to Nearly $150 Million

Willis Lease Finance Corporation Closes Two Additional JOLCO Deals, Bringing Total JOLCO Financing to Nearly $150 Million

Willis Lease Finance Corporation announced the closing of two additional Japanese Operating Lease with Call Option (JOLCO) transactions, totaling approximately $50 million in financing for LEAP-1A and LEAP-1B aircraft engines. These deals increase the company's total JOLCO financing to nearly $150 million and provide diversified term financing to s…

Nexxen Announces March 2026 Share Repurchase Program Summary

Nexxen Announces March 2026 Share Repurchase Program Summary

Nexxen International Ltd., an advertising technology company traded on NASDAQ, completed its $20 million share repurchase program by buying back over 224,000 shares in March 2026. The company now announces a new, larger $40 million repurchase program, signaling confidence in its business and commitment to shareholder value.

Alpha Modus Awarded Foundational Patent Covering Real-Time, AI-Driven Personalized Marketing in Retail Stores

Alpha Modus Awarded Foundational Patent Covering Real-Time, AI-Driven Personalized Marketing in Retail Stores

Alpha Modus Holdings, Inc. announced the issuance of U.S. Patent No. 12,591,901 covering innovative AI-driven methods for real-time, personalized marketing in physical retail stores. This foundational patent secures the company's leadership in leveraging in-store behavioral data to deliver dynamic, shopper-specific promotions and pricing via variou…

FirstService Announces Election of Directors

FirstService Announces Election of Directors

FirstService Corporation announced the election of eight directors at its annual and special shareholders' meeting. Shareholders also approved the appointment of PricewaterhouseCoopers LLP as auditor, amendments to the stock option plan, and a non-binding advisory resolution on executive compensation. FirstService operates as a leading property ser…

FibroBiologics Announces Pricing of $3 Million Public Offering

FibroBiologics Announces Pricing of $3 Million Public Offering

FibroBiologics, a clinical-stage biotechnology company specializing in fibroblast-based therapeutics, announced the pricing of a best efforts public offering to raise approximately $3 million through the sale of shares and warrants. The offering is subject to stockholder approval and expected to close around April 2, 2026. Net proceeds will be used…

Covenant Logistics Group, Inc. Announces Timing Of First Quarter Earnings Release And Conference Call

Covenant Logistics Group, Inc. Announces Timing Of First Quarter Earnings Release And Conference Call

Covenant Logistics Group, Inc. plans to release its first quarter earnings after market close on April 23, 2026. A live conference call to discuss the earnings will be held on April 24, 2026. The company provides transportation and logistics services across the U.S., including asset-based expedited and dedicated truckload capacity, warehousing, tra…

Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Sight Sciences, Inc. announced that clinical data for its OMNI Surgical System and TearCare System will be presented at the 2026 ASCRS Annual Meeting, showcasing the durability and clinical benefits of its interventional technologies for glaucoma and dry eye disease. The new data highlight the significant reduction in intraocular pressure fluctuati…

QCR Holdings, Inc. to Report First Quarter 2026 Financial Results

QCR Holdings, Inc. to Report First Quarter 2026 Financial Results

QCR Holdings, Inc. plans to release its first quarter 2026 financial results on April 22, 2026, followed by a conference call and webcast discussion on April 23, 2026. The company operates multi-bank holding subsidiaries serving several Midwestern communities with banking, trust, and wealth management services, holding $9.6 billion in assets as of …